Pulmotect
PrivateLast Round
Series C
Sep 17, 2024
Total Funding Raised
$45.63M
Company Overview
Pulmotect is a biotechnology company developing PUL-042, a clinical-stage, inhaled therapeutic that stimulates the innate immune system to provide broad-spectrum protection against respiratory infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pulmotect Comps
Public and private peers based on sector, stage, and business model.
Pulmotect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Seed Round | Jan 16, 2024 | ||||
| Grant | May 30, 2023 | ||||
| Grant | Jan 27, 2021 | ||||
| Series B | Apr 4, 2018 | ||||
Series A | Apr 5, 2016 |
Pulmotect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fannin Innovation Studio | Series A, Series C, Series B |
| Jefferson River Capital | Series B |
| U.S. Department of War | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Axil Capital | Series C |
| Aquinas Companies, LLC | Series B |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2024
Raised $3.66M in a Seed Round.
Pulmotect Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pulmotect's valuation, stock price, and market status.
